Obesity and Cardiovascular Disease

Obesity is a risk marker for cardiovascular disease. The major effects of obesity on cardiovascular (CV) health are mediated through the risk of metabolic syndrome (insulin-resistance, dyslipidemia, and hypertension), such that an absence of these risk factors in obese individuals may not be associated with increased mortality risk. Obesity is associated with an increased risk of morbidity and mortality as well as reduced life and expectancy.  Men are apt to develop visceral type obesity while women develop the peripheral type. Corticosteroids and growth hormone also tend to develop visceral obesity.

  • Hypertension
  • Endothelial dysfunction
  • Left Ventricular Hypertrophy
  • Diabetes
  • Congestive Heart Failure

Related Conference of Obesity and Cardiovascular Disease

July 10- 11, 2018

19th World Obesity Congress

Bangkok, Thailand
July 26-27, 2018

20th Annual congress on Eating Disorders, Obesity and Nutrition

Amsterdam, Netherlands, Venue: HYATT PLACE AMSTERDAM AIRPORT
August 24-25, 2018

20th Global Obesity Meeting

Singapore
August 28-29, 2018

17th International Conference on Obesity, Diet and Nutrition

Paris, France. Venue: Holiday Inn Paris – Marne La Vallee

Dallas, Texas, USA
September 13-14, 2018

14th Euro Obesity and Endocrinology Congress

London, UK
September 21-22, 2018

17th World Congress on Obesity & Nutrition

Osaka, Japan
October 25-26, 2018

21st World Obesity Conference

Budapest, Hungary
November 29-30, 2018

International Conference on Obesity and Diet Imbalance

Bali, Indonesia

Obesity and Cardiovascular Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in